179 related articles for article (PubMed ID: 35986741)
1. MIR-518a-5p Targets ZEB2 to Suppress the Migration and Invasion of Breast-cancer Cells.
Wang L; Guo Z; Zhang S; Zhang X; Sang M; Liu Y; Shan B
Altern Ther Health Med; 2023 Jan; 29(1):137-143. PubMed ID: 35986741
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2.
He J; Wang J; Li S; Li T; Chen K; Zhang S
Cancer Sci; 2020 Oct; 111(10):3550-3563. PubMed ID: 32726486
[TBL] [Abstract][Full Text] [Related]
3. Paeonol inhibits human lung cancer cell viability and metastasis in vitro via miR-126-5p/ZEB2 axis.
Lv J; Zhu S; Chen H; Xu Y; Su Q; Yu G; Ma W
Drug Dev Res; 2022 Apr; 83(2):432-446. PubMed ID: 34636432
[TBL] [Abstract][Full Text] [Related]
4. Circ_0000189 Promotes the Malignancy of Glioma Cells via Regulating miR-192-5p-ZEB2 Axis.
Yang J; Hou G; Chen H; Chen W; Ge J
Oxid Med Cell Longev; 2022; 2022():2521951. PubMed ID: 36193069
[TBL] [Abstract][Full Text] [Related]
5. MiR-17-5p Inhibits the Proliferation and Metastasis of Gastric Cancer Cells by Targeting PTEN Protein.
Yifei S; Chunxiao H; Dinuo L
Altern Ther Health Med; 2022 Nov; 28(8):23-29. PubMed ID: 35839114
[TBL] [Abstract][Full Text] [Related]
6. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
7. CircMMP11 regulates proliferation, migration, invasion, and apoptosis of breast cancer cells through miR-625-5p/ZEB2 axis.
Qi L; Sun B; Yang B; Lu S
Cancer Cell Int; 2021 Feb; 21(1):133. PubMed ID: 33632213
[TBL] [Abstract][Full Text] [Related]
8. Long intergenic non-protein coding RNA 847 promotes laryngeal squamous cell carcinoma progression through the microRNA-181a-5p/zinc finger E-box binding homeobox 2 axis.
Li W; Hu X; Huang X
Bioengineered; 2022 Apr; 13(4):9987-10000. PubMed ID: 35435130
[TBL] [Abstract][Full Text] [Related]
9. MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2.
Zhu D; Gu L; Li Z; Jin W; Lu Q; Ren T
Pathol Res Pract; 2019 May; 215(5):861-872. PubMed ID: 30712885
[TBL] [Abstract][Full Text] [Related]
10. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
Ji H; Sang M; Liu F; Ai N; Geng C
Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway.
Yang S; Li X; Shen W; Hu H; Li C; Han G
J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055
[TBL] [Abstract][Full Text] [Related]
12. MiR-379-5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A.
Yang K; Li D; Jia W; Song Y; Sun N; Wang J; Li H; Yin C
Thorac Cancer; 2022 Jul; 13(13):1916-1924. PubMed ID: 35608059
[TBL] [Abstract][Full Text] [Related]
13. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
14. Lnc NR2F1-AS1 Promotes Breast Cancer Metastasis by Targeting the MiR-25-3p/ZEB2 Axis.
Zhai D; Zhou Y; Kuang X; Shao F; Zhen T; Lin Y; Wang Q; Shao N
Int J Med Sci; 2023; 20(9):1152-1162. PubMed ID: 37575267
[No Abstract] [Full Text] [Related]
15. CircCRIM1 promotes ovarian cancer progression by working as ceRNAs of CRIM1 and targeting miR-383-5p/ZEB2 axis.
Du Y; Liu X; Zhang S; Chen S; Guan X; Li Q; Chen X; Zhao Y
Reprod Biol Endocrinol; 2021 Nov; 19(1):176. PubMed ID: 34847936
[TBL] [Abstract][Full Text] [Related]
16. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
[TBL] [Abstract][Full Text] [Related]
17. Sevoflurane Suppresses the Migration, Invasion, and Epithelial-Mesenchymal Transition of Breast Cancer Cells Through the miR-139-5p/ARF6 Axis.
Wu T; Sun L; Wang C; Yu P; Cheng L; Chen Y
J Surg Res; 2021 Feb; 258():314-323. PubMed ID: 33317757
[TBL] [Abstract][Full Text] [Related]
18. MiR-454-3p and miR-374b-5p suppress migration and invasion of bladder cancer cells through targetting ZEB2.
Wang S; Zhang G; Zheng W; Xue Q; Wei D; Zheng Y; Yuan J
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352837
[TBL] [Abstract][Full Text] [Related]
19. LncRNA TUG1 promotes the progression of colorectal cancer via the miR-138-5p/ZEB2 axis.
Yan Z; Bi M; Zhang Q; Song Y; Hong S
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32391554
[TBL] [Abstract][Full Text] [Related]
20. miR-215-5p Plays a Key Role in Suppressing Vascular Invasion and Recurrence in Hepatocellular Carcinoma by Blocking Vasculogenic Mimicry.
Zhang H; Lan X; Cai L; Gao X; Gao F; Yu D; Zhang J; Zhang J; Tai Q
Front Biosci (Elite Ed); 2024 Feb; 16(1):6. PubMed ID: 38538524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]